Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors in the central nervous system, conolidine modulates alternate molecular targets. A Science Innovations review discovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. https://alternativenaturalpainrel16926.blogdosaga.com/38624557/the-best-side-of-alternative-natural-pain-relief-to-replace-traditional-painkillers